Skip to main content

Table 1 Results for outcomes: fatigue, pain, anxiety, depression, health distress, self-efficacy, and SF-36 at baseline, pre-intervention, post-intervention, 6- and 12-months follow up. Data are mean (SD)

From: Evaluation of a disease specific rheumatoid arthritis self-management education program, a single group repeated measures study

Outcomes

Baseline

Pre-Ix

Post-Ix

6 Months

12 Months

Fatigue (0–10)

6.1 (2.4)

5.7 (2.4)

5.1 (2.6)a

5.2 (2.7)

5.2 (2.9)

Pain (0–10)

5.1 (2.4)

4.9 (2.2)

4.8 (2.7)

4.9 (2.7)

4.4 (2.9)

Anxiety (0–21)

7.8 (4.1)

7.4 (3.9)

6.9 (3.9)

6.7 (4.0)a

6.7 (4.5)

Depression (0–21)

6.1 (3.8)

6.3 (4.3)

5.6 (3.9)a

5.2 (3.8)a

4.9 (3.9)a

Health distress (0–5)

2.3 (1.1)a

2.1 (1.1)

2.0 (1.0)

1.7 (1.2)a

1.4 (1.1)a

Self-efficacy (0–10)

5.5 (2.1)a

5.9 (1.9)

6.1 (2.1)

6.1 (2.3)

5.9 (2.8)

SF-36 (0–100)

     

Mental health

44.1 (10.6)

44.5 (11.1)

46.5 (9.5)a

47.2 (10.6)a

47.8 (10.9)a

Role emotional

40.5 (13.4)

41.5 (13.2)

42.6 (13.4)

45.3 (13.1)a

46.5 (11.8)a

Social function

39.6 (12.3)a

41.5 (12.1)

42.1 (11.1)

42.8 (13.1)

43.3 (11.9)

Vitality

38.8 (10.3)a

40.9 (10.9)

41.7 (10.4)

43.7 (11.5)a

43.7 (12.2)a

General health

39.3 (10.9)

40.2 (11.5)

39.3 (11.3)

41.0 (11.6)

41.5 (11.5)

Bodily pain

37.3 (7.2)a

38.9 (7.6)

38.8 (7.5)

39.8 (9.0)

40.6 (9.4)

Role physical

32.7 (10.2)a

35.0 (11.0)

36.2 (12.1)

39.3 (13.0)a

40.2 (12.1)a

Physical function

34.6 (11.0)

34.8 (11.5)

35.6 (11.3)

37.3 (11.4)a

38.6 (10.7)a

  1. asignificantly different to pre-intervention (p < 0.05). Repeated measures ANOVA
  2. Decreasing scores in fatigue, pain, anxiety, depression and health distress signify improvement, while increasing scores in self-efficacy and SF-36 signify improvement
  3. Ix Intervention